Home
Welcome to Lloyd Wright's Hepatitis C Message Board
Go Out Plex Testimonial
Wednesday, 24 June 2009
From: Ruby
Sent: Tuesday, June 16, 2009 9:29 PM
To: Lloyd Wright
Subject:

Lloyd after ordering product go-out plex then and then only did I know that my weight gain is most likely caused from flu lid build up. About a week of this product and my anchles are normal looking my legs are also getting better. I also take oxymatrine and many other that you have. I would like to thank you from the bottom of my heart.

again thank
you ruby from Texas

 
V.E.P
Thursday, 18 June 2009

Get the V.E.P. HERE 

Viral Eradicator Package

$105.00

 

Lloyd’s package deals are offered at a discounted rate
and given
FREE shipping!

 

Quantity

Product

Recommended Dosage

1

Liver Formula II, 120 caps.

3 caps before breakfast

1

Laktoferrin, 90 caps., 350 mg.

3 caps before bed

1

Naringenin, 120 caps., 500 mg.

2 caps with each meal

1

Oxymatrine, 100 caps., 300 mg.

1 cap with a meal
up to three time per day


 

Only $105.00

(w/Free Shipping PLUS a savings of $28)

(Plus California sales tax if applicable).

 

Please note: feel free to add items to any of Lloyd’s package deals and pay shipping only on the added items.

 

No Substitutions!

Prices are subject to change without notice.

Get the V.E.P. HERE

Note: These statements have not been evaluated by the FDA.
The product is not intended to diagnose, treat, cure, or prevent any disease.

 
FibroTest attributes to generate decision trees in hepatitis C
Wednesday, 17 June 2009
It is about time, I been pushing this since 2003 and so many people have had to argue with their doctor to get it, they all think it is a bad inaccurate thing to do because they do not get a commission on it like they do a biopsy.
Lloyd

In recent years the use of non-invasive biomarkers to assess liver fibrosis has become widely accepted. Although the combination of surrogate markers, such as those employed by the FibroTest, have a high predictive value for the assessment of significant fibrosis, it is important to find tools that can improve its accuracy, particularly in intermediate stages and to reinforce its reliability by ensuring that the classification results are independent of contingent features of the classification technique.

A research article to be published in the World Journal of Gastroenterology explored the automatic generation of decision trees to simplify a classification process and to provide additional information to support the classification rational. The research group, led by Dr. Kershenobich from México´s National University (UNAM), used the C4.5 classification algorithm to construct decision trees with data from 261 patients with chronic hepatitis C without a liver biopsy. The FibroTest attributes (age, gender, bilirubin, apolipoprotein, haptoglobin, 2 macroglobulin, and glutamyl transpeptidase) were used as predictors, and the FibroTest score as the target.

The construction of decision trees using the FibroTest attributes provided explicit rules to relate the range of values of the biomarkers with fibrosis scores, and they might help in gaining a better grasp of the importance and significance of the test.

Analysis, such as the one performed in the present work, could help to further classify preclinical subgroups and identify subclasses of rapid or slower fibrosers. This classification should enhance our ability to assess differences in fibrosis scores in clinical studies and improve our understanding of fibrosis progression.

The present work is the result of a group effort between members of the Department of Experimental Medicine of the Faculty of Medicine and the Institute of Applied Mathematics at the Universidad Nacional Autonoma of Mexico (UNAM), which provided a grant to support the investigation.

Source: World Journal of Gastroenterology (web)
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>

Results 1 - 14 of 257
© 2009 Lloyds Hepatitis C Message Board
Joomla! is Free Software released under the GNU/GPL License.